For the current REF see the REF 2021 website REF 2021 logo

Output details

1 - Clinical Medicine

Imperial College London

Return to search Previous output Next output
Output 0 of 0 in the submission
Article title

First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected children: an open-label, randomised phase 2/3 trial.

Type
D - Journal article
Title of journal
The Lancet Infectious Diseases
Article number
-
Volume number
11
Issue number
4
First page of article
273
ISSN of journal
1474-4457
Year of publication
2011
URL
-
Number of additional authors
16
Additional information

The author made a substantial contribution to the conception and design of the study and to the organisation of the conduct of the study and to carrying out the study (including acquisition of study data) and to analysis and interpretation of study data.

The author helped draft the output and critique the output for important intellectual content.

Interdisciplinary
-
Cross-referral requested
-
Research group
D - Infection, Immunology and Inflammation
Citation count
32
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-